More functional DNA in mitochondria cures male infertility

Microscopy image of mouse testis Max Planck Institute for Biology of Ageing

Worldwide approximately nine percent of women and men are involuntarily childless. In 40 to 50 percent of the cases this is due to male infertility.

This infertility can be caused by different reasons, one of them are mutations in the mitochondrial DNA.

Mitochondria are tiny energy factories inside the cell and harbor their own independent genome – the mitochondrial DNA (mtDNA).

Mice suffering from a high number of mutations in the mtDNA are infertile and have fewer and less motile sperm.

Max Planck scientist Min Jiang and her colleagues studied these mice and found a way to overcome the consequences of these mutations.

”We increased the total amount of mtDNA in the mitochondria of the testis. This did not change the proportion of mtDNA with mutations, but it increased the absolute number of non-mutated mtDNA, which restored mitochondrial energy production and semen quality”, explains Jiang.

As a next step the researchers want to screen for pharmaceuticals, which could stimulate total mtDNA amount in the testis.

“We hope to find an efficient future strategy to treat or even cure patients suffering from infertility caused by mtDNA mutations”, says Jiang.

http://www.age.mpg.de

Media Contact

Dr. Maren Berghoff Max-Planck-Institut für Biologie des Alterns

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

Lower dose of mpox vaccine is safe

… and generates six-week antibody response equivalent to standard regimen. Study highlights need for defined markers of mpox immunity to inform public health use. A dose-sparing intradermal mpox vaccination regimen…

Efficient, sustainable and cost-effective hybrid energy storage system for modern power grids

EU project HyFlow: Over three years of research, the consortium of the EU project HyFlow has successfully developed a highly efficient, sustainable, and cost-effective hybrid energy storage system (HESS) that…

Safer alternative for an explosive reaction

The chemical industry has been using a reaction with explosive chemicals for over 100 years – now Mülheim scientists have discovered a safer alternative. The Ritter Group of the Max…

Partners & Sponsors